The forecasted sales of antihypertensive medicine in Germany indicate slight but steady growth from 2024 to 2028, starting at $357.1 million in 2024 and reaching $357.6 million by 2028. This represents a minimal year-on-year increase, highlighting a market that is largely stable. Given that 2024 data is already consistent with previous years, growth since 2023 has been negligible, indicating a potential saturation in the market.

Future trends to watch for include:

The impact of demographic changes such as an aging population, which may increase demand for antihypertensive medications.
Possible new product innovations or generic drug entries affecting market dynamics.
Regulatory changes and healthcare policy shifts potentially influencing prescription practices and sales.